Nicolas Badenco
A5064468149- Cardiac Arrhythmias and Treatments
- Cardiac pacing and defibrillation studies
- Atrial Fibrillation Management and Outcomes
- Cardiovascular Effects of Exercise
- Cardiac electrophysiology and arrhythmias
- Cardiac Arrest and Resuscitation
- Cardiac Structural Anomalies and Repair
- Cardiac Valve Diseases and Treatments
- Cardiomyopathy and Myosin Studies
- Cardiovascular Syncope and Autonomic Disorders
- Transplantation: Methods and Outcomes
- Cardiovascular Function and Risk Factors
- Sports injuries and prevention
- Neurological disorders and treatments
- Congenital Heart Disease Studies
- Antiplatelet Therapy and Cardiovascular Diseases
- Venous Thromboembolism Diagnosis and Management
- Cardiac Imaging and Diagnostics
- Sarcoidosis and Beryllium Toxicity Research
- Viral Infections and Immunology Research
- Health Systems, Economic Evaluations, Quality of Life
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Cardiac tumors and thrombi
- Ear Surgery and Otitis Media
- Vasculitis and related conditions
Sorbonne Université
2016-2025
Pitié-Salpêtrière Hospital
2016-2025
Fondation pour l’innovation en Cadiométabolisme et Nutrition
2015-2025
Assistance Publique – Hôpitaux de Paris
2016-2025
Université Sorbonne Paris Nord
2025
Johns Hopkins University
2023
Unité de recherche sur les maladies cardiovasculaires et métaboliques
2018-2022
Clinique Pasteur
2020-2022
University of Liverpool
2022
Liverpool Heart and Chest Hospital
2022
The subcutaneous (S) implantable cardioverter-defibrillator (ICD) is safe and effective for sudden cardiac death prevention. However, patients in previous S-ICD studies had fewer comorbidities, less left ventricular dysfunction, received more inappropriate shocks (IAS) than typical transvenous ICD trials. UNTOUCHED trial (Understanding Outcomes With the Primary Prevention Patients Low Ejection Fraction) was designed to evaluate IAS rate a typical, contemporary patient population implanted...
Abstract Aims Treatment guidelines for patients with atrial fibrillation (AF) suggest that should be managed an antiarrhythmic drug (AAD) before undergoing catheter ablation (CA). This study evaluated whether pulmonary vein isolation employing cryoballoon CA is superior to AAD therapy the prevention of arrhythmia (AA) recurrence in rhythm control naive paroxysmal AF (PAF). Methods and results A total 218 treatment symptomatic PAF were randomized (1 : 1) (Arctic Front Advance, Medtronic) or...
Background: Recurrences of atrial fibrillation (AF) after pulmonary vein isolation (PVI) are mainly due to reconnection. However, a growing number patients have AF recurrences despite durable PVI. The optimal ablative strategy for these is unknown. We analyzed the impact current ablation strategies in large multicenter study. Methods: Patients undergoing redo and presenting PVI were included. freedom from arrhythmia vein-based, linear-based, electrogram-based, trigger-based compared....
Little is known about patients with right bundle branch block (RBBB)-ventricular tachycardia (VT) and arrhythmogenic cardiomyopathy (ACM). Our aims were: (i) to describe electrocardiogram (ECG) characteristics of sinus rhythm (SR) VT; (ii) correlate SR RBBB-VT ECGs; (iii) compare VT ECGs electro-anatomic mapping (EAM) data.From the European Survey on ACM, 70 spontaneous were included. Putative left ventricular (LV) sites origin (SOOs) estimated a VT-axis-derived methodology confirmed by EAM...
Abstract Background Substrate ablation strategies in addition to pulmonary vein isolation (PVI) for the maintenance of sinus rhythm (SR) are still debated. Targeting low voltage areas (LVA) PVI may represent an efficient strategy persistent atrial fibrillation (AF). Purpose SCAR-AF study (ablation LVA during rhythm) was a multicenter, prospective, randomized trial, evaluating effect AF on SR maintenance. Methods From September 2019 August 2021, patients with de novo were included study....
Abstract Background While strong evidence supports omitting defibrillation testing (DT) in transvenous implantable cardioverter defibrillator (ICD), the same cannot be assumed for subcutaneous ICD (S-ICD), where DT is still recommended due to limited evidence. Purpose This study aims compare long-term outcomes of S-ICD recipients with and without DT, focusing on cause-specific mortality, especially sudden cardiac death (SCD), incidence shocks. Methods We analyzed data from HONEST cohort,...
BACKGROUND: The real incidence of atrial arrhythmia (AA) after patent foramen ovale (PFO) closure and whether this complication can be prevented remain unknown. We assessed flecainide is effective to prevent AA during the first 3 months PFO closure, 6 treatment with more than closure. METHODS: AFLOAT (Assessment Flecainide Lower Patent Foramen Ovale Closure Risk Atrial Fibrillation or Tachycardia Trial) a prospective, multicentre, randomized, open-label, superiority trial blind evaluation...
Abstract Background Ablation index (AI) is a new lesion quality marker that has been demonstrated to allow high single‐procedure arrhythmia‐free survival in single‐center studies. This prospective, multi‐center study was designed evaluate the reproducibility of pulmonary vein (PV) isolation guided by AI. Methods A total 490 consecutive patients with paroxysmal (80.4%) and persistent AF underwent first time PV were divided four groups according operator's preference choosing ablation catheter...
Atrial fibrillation (AF) ablation outcome is still operator dependent. Ablation Index (AI) a new lesion quality marker that has been demonstrated to allow acute durable pulmonary vein (PV) isolation followed by high single-procedure arrhythmia-free survival. This prospective, multicenter study was designed evaluate the reproducibility of PV guided AI.A total 490 consecutive patients with paroxysmal (80.4%) and persistent AF underwent first time encircling were divided in four groups...